end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedProfessionalFeesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AmortizationOfDebtDiscountPremium,AmortizationOfFinancingCosts,Assets,AssetsCurrent,AssetsNoncurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConvertibleLongTermNotesPayable,DebtInstrumentUnamortizedDiscount,DeferredFinanceCostsNoncurrentNet,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DerivativeLiabilitiesNoncurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability,EmployeeRelatedLiabilitiesCurrent,FederalIncomeTaxExpenseBenefitContinuingOperations,GeneralAndAdministrativeExpense,GrantsReceivableCurrent,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeTaxExaminationPenaltiesAndInterestAccrued,IncomeTaxExaminationPenaltiesAndInterestExpense,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestIncomeExpenseNonoperatingNet,InterestPayableCurrent,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesNoncurrent,LossContingencyClaimsDismissedNumber,LossContingencyNewClaimsFiledNumber,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OtherAssetsCurrent,OtherPrepaidExpenseCurrent,PaymentsOfStockIssuanceCosts,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidInsurance,ProceedsFromConvertibleDebt,ProceedsFromIssuanceOfCommonStock,ProceedsFromStockOptionsExercised,ProfitLoss,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,SecurityDeposit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue,StateAndLocalIncomeTaxExpenseBenefitContinuingOperations,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueIssuedForServices,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityParOrStatedValuePerShare,UnrealizedGainLossOnDerivatives,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2019-12-31,2020-03-25,10-K,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,1233877.0,103300.0,200600.0,8483.0,,3738.0,1191.0,1117107.0,747512.0,369595.0,1858.0,1858.0,-33454.0,0.0001,10150000.0,282614.0,282614.0,28.0,499807.0,22762.0,7431.0,1630299.0,0.0,1430716.0,137826.0,37708.0,1630299.0,106000.0,,-3.51,,0.0,0.21,-0.294,0.004,,0.08,106000.0,131530.0,0.0,829366.0,735075.0,-990980.0,0.0,,0.0,969091.0,182409.0,-5101.0,-40933.0,36041.0,2616555.0,1117107.0,2010748.0,605807.0,,,443088.0,-476542.0,-990980.0,614642.0,1605622.0,-1605622.0,34351.0,,4135.0,157222.0,0.0001,0.0,,,,530000.0,,,-990980.0,776256.0,-8777028.0,0.0,6444.0,8483.0,,,,,,,1283.0,0.0,,,352282.0,0.19,,,0.14,,,,0.0,-8576400.0,,,,,0.0001,-79500.0,291575.0,,282614.0,,,,,
2020-03-31,2020-05-05,10-Q,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,54530.0,155787.0,19909820.0,,,396.0,129.0,11441186.0,11441186.0,,11120465.0,11120465.0,11118607.0,0.0001,35000000.0,6845459.0,6845459.0,685.0,,,,,,,,,,,,-0.1,,,,,,,,,21482.0,,516716.0,37752.0,-441590.0,,,0.0,-982986.0,2213.0,272390.0,10634.0,,749299.0,11441186.0,749299.0,,,,12089012.0,-970405.0,-441590.0,141572.0,583162.0,-583162.0,10479.0,5239.0,4014.0,,0.0001,2000000.0,,,267272.0,,12084406.0,4606.0,-441590.0,66446.0,-9218618.0,0.0,6444.0,0.0,,,,1001283.0,,,,0.0,,,324996.0,,,,,,,,,10691887.0,,,11955795.0,4606.0,,-26500.0,,,4599469.0,,,,,
2020-06-30,2020-07-29,10-Q,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,124445.0,31212.0,21025701.0,1111272.0,,,,10201216.0,10201216.0,,9763270.0,9763270.0,,0.0001,35000000.0,6866608.0,6866608.0,687.0,,22762.0,7431.0,,,,,,,,,-0.34,,,,,,,,,18279.0,,1687151.0,199221.0,-2309490.0,,,0.0,,,,25878.0,,702936.0,10201216.0,702936.0,,,,,,-2309490.0,234139.0,2543629.0,-2543629.0,10336.0,,38708.0,,0.0001,2000000.0,,,193573.0,,,,,856478.0,-11528108.0,,6444.0,1111272.0,0.0,0.8,0.004,401283.0,,,,,,,903847.0,,853847.0,,,,,1.99,,9498280.0,,,,4611.0,,,,,6860847.0,,,,,
2020-09-30,2020-11-04,10-Q,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,139778.0,86454.0,21654718.0,607067.0,,,,9402001.0,9402001.0,,8840607.0,8840607.0,,0.0001,35000000.0,6871608.0,6871608.0,687.0,,,,,,,,,,,-0.15,-0.15,-0.15,,,,,,,,16493.0,,884859.0,424952.0,-1006354.0,,,0.0,,,,10500.0,,281058.0,9402001.0,281058.0,,,,,,-1006354.0,597403.0,1603757.0,-1603757.0,10394.0,,19941.0,,0.0001,2000000.0,,,110057.0,,,,,718898.0,-12534462.0,,6444.0,629017.0,,,,186283.0,,,,,,,1113847.0,,1063847.0,,,,,,,9120943.0,,21950.0,,,,,,6871554.0,6871554.0,6871554.0,,,,
2020-12-31,2021-03-03,10-K,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,341856.0,216198.0,21779340.0,1742163.0,,396.0,129.0,8119334.0,8119334.0,,8074658.0,8074658.0,8072800.0,0.0001,35000000.0,6891608.0,6891608.0,689.0,,,,3249815.0,0.0,2460773.0,241414.0,547628.0,3249815.0,,-0.87,-0.87,-0.87,0.0,0.21,-0.297,-0.008,0.019,0.076,,16493.0,0.0,3586196.0,,-5462047.0,0.0,0.0,,-695660.0,-406032.0,34097.0,47225.0,,578380.0,8119334.0,578380.0,,,,12043623.0,-3970823.0,-5462047.0,1178174.0,6640221.0,-6640221.0,41603.0,,11690.0,,0.0001,2000000.0,0.0,0.0,26542.0,,12034406.0,9217.0,-5462047.0,3054025.0,-14239075.0,0.0,6444.0,1864913.0,,,,,1061466.0,2.54,2381.0,810000.0,2.19,5523826.0,1111466.0,2.57,1061466.0,0.19,0.14,3.46,5303326.0,,0.0,7540954.0,48435.0,122750.0,11955795.0,9217.0,0.0001,-26500.0,1619516.0,6308961.0,6308961.0,6308961.0,-0.008,,196976.0,
2021-03-31,2021-05-06,10-Q,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,824565.0,363898.0,21806328.0,23977.0,,,,5964956.0,5964956.0,,5602807.0,5602807.0,-2471851.0,0.0001,35000000.0,6947120.0,6947120.0,695.0,,,,,,,,,,,,-0.46,,,,,,,,,392885.0,,839627.0,,-3199673.0,,,0.0,482709.0,535592.0,317473.0,197.0,,1596681.0,5964956.0,1596681.0,,,,3017.0,-2474868.0,-3199673.0,29537.0,3229210.0,-3229210.0,10615.0,,58485.0,,0.0001,2000000.0,0.0,0.0,297220.0,,,3017.0,-3199673.0,2389583.0,-17438748.0,0.0,6444.0,23977.0,,,,168664.0,,,,0.0,,,1107598.0,,1057598.0,,,,,,,4368275.0,,,,3017.0,,,,,6920622.0,,,,,
2021-06-30,2021-07-28,10-Q,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,114828.0,353977.0,68574704.0,7992.0,,,,49496238.0,49496238.0,,49224198.0,49224198.0,,0.0001,35000000.0,8090932.0,8090932.0,809.0,,,,,,,,,,,,-0.34,,,,,,,,,388437.0,,709648.0,,-2524602.0,,,,,,,2134.0,,884075.0,49496238.0,884075.0,,,,,,-2524602.0,9548.0,2534150.0,-2534150.0,12575.0,,48283.0,,0.0001,2000000.0,0.0,0.0,213892.0,,,,,1824502.0,-19963350.0,,9865.0,,,,,1168664.0,,,,,,,961653.0,,,,,,,,,48612163.0,,,46668413.0,92085.0,,,,,7366654.0,,,,,
2021-09-30,2021-11-03,10-Q,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,289742.0,548842.0,69340645.0,785942.0,20000.0,,,47650490.0,47650490.0,,47455334.0,47455334.0,,0.0001,35000000.0,8100570.0,8100570.0,810.0,,,,,,,,,,,-0.35,,-0.35,,,,,,,,243684.0,,1472969.0,,-2848216.0,,,0.0,,,,5554.0,,1120601.0,47650490.0,1120601.0,,2.0,2.0,,,-2848216.0,5554.0,2853770.0,-2853770.0,13410.0,,63790.0,,0.0001,2000000.0,0.0,0.0,121501.0,,,,,1380801.0,-22811566.0,,9865.0,,,,,1084464.0,,,,,,,1035853.0,,951653.0,,,,,,,46529889.0,,,,,,,,8099103.0,,8099103.0,,,,
2021-12-31,2022-03-02,10-K,"Annovis Bio,Â Inc.",ANVS,CIK0001477845,USD,688074.0,105672.0,73220361.0,4697627.0,,,,46001478.0,46001478.0,,45686014.0,45686014.0,37611356.0,0.0001,35000000.0,8100570.0,8100570.0,810.0,,,,10921886.0,0.0,6512249.0,648077.0,1759129.0,10921886.0,,-1.9,,-1.9,0.0,0.21,-0.529,,0.024,0.137,,712768.0,0.0,6058190.0,,-14487132.0,0.0,0.0,,346218.0,581916.0,270788.0,13335.0,,1506514.0,46001478.0,1506514.0,,,2.0,46743515.0,-9132159.0,-14487132.0,50089.0,14537221.0,-14537221.0,51760.0,,43736.0,,0.0001,2000000.0,0.0,0.0,29111.0,,46648413.0,95102.0,-14487132.0,8479031.0,-28726207.0,0.0,9865.0,4697627.0,,,,,1105568.0,5.87,,538095.0,27.13,14325377.0,1489748.0,13.82,,2.83,,33.78,14325377.0,,0.0,44494964.0,159813.0,,46648413.0,95102.0,,,7672071.0,7626278.0,,7626278.0,0.001,0.157,11163998.0,0.0
